These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 38995307

  • 1. Effectiveness of Supramaximal Angiotensin-converting Enzyme Inhibition in Controlling Proteinuria in Congenital Nephrotic Syndrome with Cytomegalovirus Infection and an NPHS1 Mutation.
    Dange N, Sathe KP, Kondekar A, Sawant V.
    Saudi J Kidney Dis Transpl; 2023 Sep 01; 34(5):462-467. PubMed ID: 38995307
    [Abstract] [Full Text] [Related]

  • 2. Adequate clinical control of congenital nephrotic syndrome by enalapril.
    Guez S, Giani M, Melzi ML, Antignac C, Assael BM.
    Pediatr Nephrol; 1998 Feb 01; 12(2):130-2. PubMed ID: 9543371
    [Abstract] [Full Text] [Related]

  • 3. [Congenital nephrotic syndrome].
    Hattori M.
    Nihon Rinsho; 2004 Oct 01; 62(10):1861-6. PubMed ID: 15500131
    [Abstract] [Full Text] [Related]

  • 4. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F, Ramadan R, Khankin E, Yaccob A, Kositch Z, Lewin M, Assady S, Abassi Z.
    Am J Physiol Renal Physiol; 2005 Oct 01; 289(4):F880-90. PubMed ID: 15942045
    [Abstract] [Full Text] [Related]

  • 5. Genetic Studies in Infants with Congenital Nephrotic Syndrome: A Case Series.
    Karunakar P, Chidambaram AC, Krishnamurthy S, Sivamurukan P, Deepthi B, Gowda M.
    Saudi J Kidney Dis Transpl; 2023 Mar 01; 34(2):191-195. PubMed ID: 38146730
    [Abstract] [Full Text] [Related]

  • 6. Eplerenone potentiates the antiproteinuric effects of enalapril in experimental nephrotic syndrome.
    Nakhoul F, Khankin E, Yaccob A, Kawachi H, Karram T, Awaad H, Nakhoul N, Hoffman A, Abassi Z.
    Am J Physiol Renal Physiol; 2008 Mar 01; 294(3):F628-37. PubMed ID: 18094029
    [Abstract] [Full Text] [Related]

  • 7. Neonatal nephrotic presentation of a child with heterozygous NPHS1 mutation.
    Lemley KV.
    Pediatr Nephrol; 2006 Jun 01; 21(6):864-6. PubMed ID: 16703378
    [Abstract] [Full Text] [Related]

  • 8. Plasma exchange and retransplantation in recurrent nephrosis of patients with congenital nephrotic syndrome of the Finnish type (NPHS1).
    Kuusniemi AM, Qvist E, Sun Y, Patrakka J, Rönnholm K, Karikoski R, Jalanko H.
    Transplantation; 2007 May 27; 83(10):1316-23. PubMed ID: 17519780
    [Abstract] [Full Text] [Related]

  • 9. A girl with MIRAGE syndrome who developed steroid-resistant nephrotic syndrome: a case report.
    Ishiwa S, Kamei K, Tanase-Nakao K, Shibata S, Matsunami K, Takeuchi I, Sato M, Ishikura K, Narumi S.
    BMC Nephrol; 2020 Aug 12; 21(1):340. PubMed ID: 32787808
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporine A responsive congenital nephrotic syndrome with single heterozygous variants in NPHS1, NPHS2, and PLCE1.
    Eichinger A, Ponsel S, Bergmann C, Günthner R, Hoefele J, Amann K, Lange-Sperandio B.
    Pediatr Nephrol; 2018 Jul 12; 33(7):1269-1272. PubMed ID: 29663071
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin converting enzyme inhibitor does not reduce proteinuria in an infant with congenital nephrotic syndrome of the Finnish type.
    Birnbacher R, Förster E, Aufricht C.
    Pediatr Nephrol; 1995 Jun 12; 9(3):400. PubMed ID: 7632545
    [No Abstract] [Full Text] [Related]

  • 12. Congenital nephrotic syndrome responsive to angiotensin-converting enzyme inhibition.
    Sreedharan R, Bockenhauer D.
    Pediatr Nephrol; 2005 Sep 12; 20(9):1340-2. PubMed ID: 15965772
    [Abstract] [Full Text] [Related]

  • 13. Successful treatment of steroid-resistant nephrotic syndrome associated with WT1 mutations.
    Gellermann J, Stefanidis CJ, Mitsioni A, Querfeld U.
    Pediatr Nephrol; 2010 Jul 12; 25(7):1285-9. PubMed ID: 20191369
    [Abstract] [Full Text] [Related]

  • 14. Recurrence of proteinuria following renal transplantation in congenital nephrotic syndrome of the Finnish type.
    Srivastava T, Garola RE, Kestila M, Tryggvason K, Ruotsalainen V, Sharma M, Savin VJ, Jalanko H, Warady BA.
    Pediatr Nephrol; 2006 May 12; 21(5):711-8. PubMed ID: 16518627
    [Abstract] [Full Text] [Related]

  • 15. Congenital nephrotic syndrome (NPHS1): features resulting from different mutations in Finnish patients.
    Patrakka J, Kestilä M, Wartiovaara J, Ruotsalainen V, Tissari P, Lenkkeri U, Männikkö M, Visapää I, Holmberg C, Rapola J, Tryggvason K, Jalanko H.
    Kidney Int; 2000 Sep 12; 58(3):972-80. PubMed ID: 10972661
    [Abstract] [Full Text] [Related]

  • 16. Enalapril: antiproteinuric effect in children with nephrotic syndrome.
    Lama G, Luongo I, Piscitelli A, Salsano ME.
    Clin Nephrol; 2000 Jun 12; 53(6):432-6. PubMed ID: 10879662
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of enalapril in the treatment of steroid resistant idiopathic nephrotic syndrome.
    Prasher PK, Varma PP, Baliga KV.
    J Assoc Physicians India; 1999 Feb 12; 47(2):180-2. PubMed ID: 10999084
    [Abstract] [Full Text] [Related]

  • 18. [NPHS1 mutations in a Chinese family with congenital nephrotic syndrome].
    Shi Y, Ding J, Liu JC, Wang H, Bu DF.
    Zhonghua Er Ke Za Zhi; 2005 Nov 12; 43(11):805-9. PubMed ID: 16316524
    [Abstract] [Full Text] [Related]

  • 19. Enalapril and prednisone in children with nephrotic-range proteinuria.
    Delucchi A, Cano F, Rodriguez E, Wolff E, Gonzalez X, Cumsille MA.
    Pediatr Nephrol; 2000 Oct 12; 14(12):1088-91. PubMed ID: 11045392
    [Abstract] [Full Text] [Related]

  • 20. Nephropathy of cyanotic congenital heart disease: clinical characteristics and effectiveness of an angiotensin-converting enzyme inhibitor.
    Fujimoto Y, Matsushima M, Tsuzuki K, Okada M, Shibata M, Yanase Y, Usui K, Nagashima M.
    Clin Nephrol; 2002 Aug 12; 58(2):95-102. PubMed ID: 12227694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.